Back to Search Start Over

CCHFV vaccine development, current challenges, limitations, and future directions.

Authors :
Ahata, Büşra
Akçapınar, Günseli Bayram
Source :
Frontiers in Immunology; 2023, p1-18, 18p
Publication Year :
2023

Abstract

Crimean-Congo hemorrhagic fever (CCHF) is the most prevalent tick-borne viral disease affecting humans. The disease is life-threatening in many regions of the developing world, including Africa, Asia, the Middle East, and Southern Europe. In line with the rapidly increasing disease prevalence, various vaccine strategies are under development. Despite a large number of potential vaccine candidates, there are no approved vaccines as of yet. This paper presents a detailed comparative analysis of current efforts to develop vaccines against CCHFV, limitations associated with current efforts, and future research directions. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
16643224
Database :
Complementary Index
Journal :
Frontiers in Immunology
Publication Type :
Academic Journal
Accession number :
172339872
Full Text :
https://doi.org/10.3389/fimmu.2023.1238882